21587131

Source:http://linkedlifedata.com/resource/pubmed/id/21587131

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007131, umls-concept:C0457152, umls-concept:C1514474, umls-concept:C1521733
pubmed:issue	1
pubmed:dateCreated	2011-5-18
pubmed:abstractText	In pathologic IB (pIB) non-small cell lung cancer, especially in adenocarcinoma, adjuvant chemotherapy with uracil-tegafur is widely recognized as being effective. The aim of this study was to determine the prognostic factors of pIB disease.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21587131
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9703158
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1341-1098
pubmed:author	pubmed-author:FujiiYoshitakaY, pubmed-author:HikosakaYuY, pubmed-author:KawanoOsamuO, pubmed-author:MoriyamaSatoruS, pubmed-author:SasakiHidefumiH, pubmed-author:YanoMotokiM
pubmed:issnType	Print
pubmed:volume	17
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	58-62
pubmed:meshHeading	pubmed-meshheading:21587131-Adult, pubmed-meshheading:21587131-Aged, pubmed-meshheading:21587131-Aged, 80 and over, pubmed-meshheading:21587131-Antimetabolites, Antineoplastic, pubmed-meshheading:21587131-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:21587131-Chemotherapy, Adjuvant, pubmed-meshheading:21587131-Chi-Square Distribution, pubmed-meshheading:21587131-Disease-Free Survival, pubmed-meshheading:21587131-Female, pubmed-meshheading:21587131-Humans, pubmed-meshheading:21587131-Japan, pubmed-meshheading:21587131-Kaplan-Meier Estimate, pubmed-meshheading:21587131-Lung Neoplasms, pubmed-meshheading:21587131-Male, pubmed-meshheading:21587131-Medication Adherence, pubmed-meshheading:21587131-Middle Aged, pubmed-meshheading:21587131-Neoplasm Invasiveness, pubmed-meshheading:21587131-Neoplasm Staging, pubmed-meshheading:21587131-Pleura, pubmed-meshheading:21587131-Pneumonectomy, pubmed-meshheading:21587131-Proportional Hazards Models, pubmed-meshheading:21587131-Retrospective Studies, pubmed-meshheading:21587131-Risk Assessment, pubmed-meshheading:21587131-Risk Factors, pubmed-meshheading:21587131-Tegafur, pubmed-meshheading:21587131-Time Factors, pubmed-meshheading:21587131-Treatment Outcome, pubmed-meshheading:21587131-Tumor Burden, pubmed-meshheading:21587131-Young Adult
pubmed:year	2011
pubmed:articleTitle	Prognostic factors of pathologic stage IB non-small cell lung cancer.
pubmed:affiliation	Departments of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan. motoki@med.nagoya-cu.ac.jp
pubmed:publicationType	Journal Article